Why BIO-Europe 2026 matters: The evolution of strategic biop...
2026 marks a significant evolution for BIO-Europe.
Newsletters and Deep Dive digital magazine
2026 marks a significant evolution for BIO-Europe.
AI has kickstarted a new wave of innovation in biopharma R&D.
James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.
In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.
Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia
Editor's Picks
Newsletters and Deep Dive
digital magazine